Abstract
Amelioration of Type 2 hyperlipidemia by completely diverting portacaval shunt was first reported in 1973 (Starzl et al). Since then, 5 additional patients have been similarly treated by us and others have been treated elsewhere. The compiled first cases have been published (Starzl, Putnam and Koep 1978) and, doubtless more will be added by Stein in his review later today. My remarks today will be confined to a brief description of 6 patients treated at the University of Colorado from one month to 6 1/2 years ago.
This work was supported by research grants from the Veterans Administration; by grant numbers AM-17260 and AM-07772 from the National Institutes of Health; and by grant numbers RR-00051 and RR-00069 from the General Clinical Research Centers Program of the Division of Research Resources, National Institute of Health.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Putnam CW, Porter KA, Starzl TE (1976) Hepatic encephalopathy and light and electron micrographic changes of the baboon liver after portal diversion. Ann Surg 184: 155–161
Starzl TE, Chase HP, Putnam CW, Porter KA (1973) Portacaval shunt for the treatment of hyperlipoproteinemia. Lancet 2: 940–944
Starzl TE, Putnam CW, Koep LJ (1978) Portacaval shunt and hyperlipidemia. Arch Surg 113: 71–74
Editor information
Rights and permissions
Copyright information
© 1980 Springer-Verlag New York Inc.
About this paper
Cite this paper
Starzl, T.E., Koep, L., Weil, R. (1980). Portacaval Shunt for Type II Hyperlipidemia. In: Gotto, A.M., Smith, L.C., Allen, B. (eds) Atherosclerosis V. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-6071-4_87
Download citation
DOI: https://doi.org/10.1007/978-1-4612-6071-4_87
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-6073-8
Online ISBN: 978-1-4612-6071-4
eBook Packages: Springer Book Archive